One of the original Bowers-lab growth hormone-releasing peptides that seeded the entire GHRP class.
Also known as: GHRP1 · growth hormone-releasing peptide 1
Part of the Growth hormone & IGF peptides cluster
Overview
GHRP-1 is a synthetic growth hormone-releasing peptide developed from enkephalin-analog research and acting at the ghrelin/GHS receptor. It belongs to the same secretagogue family as GHRP-2, GHRP-6 and hexarelin and is studied in growth-hormone-axis research. It is not authorized by Health Canada for therapeutic use.
Source & context
Biological / chemical source: Synthetic met-enkephalin-derived GHRP
Primary research or clinical context: Research compound (not authorized by Health Canada)
Place in the GHRP family
GHRP-1 was among the earliest peptidyl growth hormone secretagogues synthesized after the discovery that enkephalin-amide analogs could release GH. It is closely related to GHRP-2, GHRP-6 and hexarelin, sharing the ghrelin-receptor mechanism rather than any sequence homology with GHRH.
Research framing
Published work examines GH release, receptor pharmacology and possible cytoprotective signaling across the GHRP class. Human clinical use is limited, and online protocols are not a substitute for controlled research design or licensed medical care. This page is educational only.
FAQ about GHRP-1
What is GHRP-1?+
GHRP-1 is a synthetic growth hormone-releasing peptide developed from enkephalin-analog research and acting at the ghrelin/GHS receptor. It belongs to the same secretagogue family as GHRP-2, GHRP-6 and hexarelin and is studied in growth-hormone-axis research. It is not authorized by Health Canada for therapeutic use.
Is GHRP-1 an approved medicine?+
GHRP-1 is discussed here as a research / educational topic. Research compound (not authorized by Health Canada). This is not medical advice.
What is the typical length of GHRP-1?+
GHRP-1 is commonly described as approximately 7 amino acids (Research peptide).